About the Authors
- Yihsuan S. Tsai
-
Contributed equally to this work with: Yihsuan S. Tsai, Yogitha S. Chareddy
Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliations UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
- Yogitha S. Chareddy
-
Contributed equally to this work with: Yihsuan S. Tsai, Yogitha S. Chareddy
Roles Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
Affiliation UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
- Brandon A. Price
-
Roles Validation, Writing – review & editing
Affiliations UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
- Joel S. Parker
-
Roles Conceptualization, Data curation, Writing – review & editing
Affiliations UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
- Chad V. Pecot
-
Roles Conceptualization, Funding acquisition, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: pecot@email.unc.edu
Affiliations UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Division of Hematology & Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
Competing Interests
We have read the journal’s policy and the authors of this manuscript have the following competing interests: C.V.P. is the founder of EnFuego Therapeutics, Inc, which is focused on the development of KRAS therapeutics and holds equity in the company. The remaining authors disclose no potential conflicts of interest.